TULIE BREW: Open Payments
NPI 1114398385 · BROOKFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,219 in 93 payments from 16 companies in 2025. Trend: 2023 $1,774 · 2024 $2,330 · 2025 $2,219
Food & beverage: $2,152Education: $66
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $479 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $269 |
| E.R. Squibb & Sons, L.L.C. | 6 | $254 |
| Teva Pharmaceuticals USA, Inc. | 10 | $247 |
| Vanda Pharmaceuticals Inc. | 7 | $161 |
| Alkermes, Inc. | 7 | $153 |
| Supernus Pharmaceuticals, Inc. | 6 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $125 |
| Neurocrine BioSciences, Inc. | 5 | $121 |
| Axsome Therapeutics, Inc. | 4 | $98 |
Products named: VRAYLAR, CAPLYTA, COBENFY, AUSTEDO XR, FANAPT, Qelbree, ARISTADA, TRINTELLIX.
Industry payments across CT — which companies pay providers there.
